IBDEI0I2 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8441,1,4,0)
 ;;=4^707.23
 ;;^UTILITY(U,$J,358.3,8441,1,5,0)
 ;;=5^Pressure Ulcer,Stage III
 ;;^UTILITY(U,$J,358.3,8441,2)
 ;;=^336651
 ;;^UTILITY(U,$J,358.3,8442,0)
 ;;=707.24^^35^484^57
 ;;^UTILITY(U,$J,358.3,8442,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8442,1,4,0)
 ;;=4^707.24
 ;;^UTILITY(U,$J,358.3,8442,1,5,0)
 ;;=5^Pressure Ulcer,Stage IV
 ;;^UTILITY(U,$J,358.3,8442,2)
 ;;=^336652
 ;;^UTILITY(U,$J,358.3,8443,0)
 ;;=707.25^^35^484^59
 ;;^UTILITY(U,$J,358.3,8443,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8443,1,4,0)
 ;;=4^707.25
 ;;^UTILITY(U,$J,358.3,8443,1,5,0)
 ;;=5^Pressure Ulcer,Unstagebl
 ;;^UTILITY(U,$J,358.3,8443,2)
 ;;=^336653
 ;;^UTILITY(U,$J,358.3,8444,0)
 ;;=707.20^^35^484^58
 ;;^UTILITY(U,$J,358.3,8444,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8444,1,4,0)
 ;;=4^707.20
 ;;^UTILITY(U,$J,358.3,8444,1,5,0)
 ;;=5^Pressure Ulcer,Stage NOS
 ;;^UTILITY(U,$J,358.3,8444,2)
 ;;=^336761
 ;;^UTILITY(U,$J,358.3,8445,0)
 ;;=110.4^^35^484^77
 ;;^UTILITY(U,$J,358.3,8445,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8445,1,4,0)
 ;;=4^110.4
 ;;^UTILITY(U,$J,358.3,8445,1,5,0)
 ;;=5^Tinea Pedis
 ;;^UTILITY(U,$J,358.3,8445,2)
 ;;=^33168
 ;;^UTILITY(U,$J,358.3,8446,0)
 ;;=078.12^^35^484^45
 ;;^UTILITY(U,$J,358.3,8446,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8446,1,4,0)
 ;;=4^078.12
 ;;^UTILITY(U,$J,358.3,8446,1,5,0)
 ;;=5^Plantar Wart
 ;;^UTILITY(U,$J,358.3,8446,2)
 ;;=^336720
 ;;^UTILITY(U,$J,358.3,8447,0)
 ;;=250.80^^35^484^24
 ;;^UTILITY(U,$J,358.3,8447,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8447,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,8447,1,5,0)
 ;;=5^Diabetic Ulcer
 ;;^UTILITY(U,$J,358.3,8447,2)
 ;;=^331811
 ;;^UTILITY(U,$J,358.3,8448,0)
 ;;=695.10^^35^484^33
 ;;^UTILITY(U,$J,358.3,8448,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8448,1,4,0)
 ;;=4^695.10
 ;;^UTILITY(U,$J,358.3,8448,1,5,0)
 ;;=5^Erythema Multiforme,Unspec
 ;;^UTILITY(U,$J,358.3,8448,2)
 ;;=^336759
 ;;^UTILITY(U,$J,358.3,8449,0)
 ;;=695.11^^35^484^32
 ;;^UTILITY(U,$J,358.3,8449,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8449,1,4,0)
 ;;=4^695.11
 ;;^UTILITY(U,$J,358.3,8449,1,5,0)
 ;;=5^Erythema Multiforme,Minor
 ;;^UTILITY(U,$J,358.3,8449,2)
 ;;=^336634
 ;;^UTILITY(U,$J,358.3,8450,0)
 ;;=695.12^^35^484^31
 ;;^UTILITY(U,$J,358.3,8450,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8450,1,4,0)
 ;;=4^695.12
 ;;^UTILITY(U,$J,358.3,8450,1,5,0)
 ;;=5^Erythema Multiforme,Major
 ;;^UTILITY(U,$J,358.3,8450,2)
 ;;=^336635
 ;;^UTILITY(U,$J,358.3,8451,0)
 ;;=695.13^^35^484^75
 ;;^UTILITY(U,$J,358.3,8451,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8451,1,4,0)
 ;;=4^695.13
 ;;^UTILITY(U,$J,358.3,8451,1,5,0)
 ;;=5^Stevens-Johnson Syndrome
 ;;^UTILITY(U,$J,358.3,8451,2)
 ;;=^336636
 ;;^UTILITY(U,$J,358.3,8452,0)
 ;;=695.14^^35^484^67
 ;;^UTILITY(U,$J,358.3,8452,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8452,1,4,0)
 ;;=4^695.14
 ;;^UTILITY(U,$J,358.3,8452,1,5,0)
 ;;=5^SJS-TEN Syndrome
 ;;^UTILITY(U,$J,358.3,8452,2)
 ;;=^336637
 ;;^UTILITY(U,$J,358.3,8453,0)
 ;;=695.15^^35^484^79
 ;;^UTILITY(U,$J,358.3,8453,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8453,1,4,0)
 ;;=4^695.15
 ;;^UTILITY(U,$J,358.3,8453,1,5,0)
 ;;=5^Toxic Epidermal Necrolysis
 ;;^UTILITY(U,$J,358.3,8453,2)
 ;;=^336638
 ;;^UTILITY(U,$J,358.3,8454,0)
 ;;=695.19^^35^484^30
 ;;^UTILITY(U,$J,358.3,8454,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8454,1,4,0)
 ;;=4^695.19
 ;;^UTILITY(U,$J,358.3,8454,1,5,0)
 ;;=5^Erythema Multiforme NEC
 ;;^UTILITY(U,$J,358.3,8454,2)
 ;;=^336639
 ;;^UTILITY(U,$J,358.3,8455,0)
 ;;=707.01^^35^484^49
 ;;^UTILITY(U,$J,358.3,8455,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI0I2
